By Michael Gwarisa Zimbabwe requires approximately US$45 million to effectively implement Antimicrobial Resistance (AMR) interventions over the next four years, HealthTimes has learned. This was revealed during the official launch of the National Action Plan for Antimicrobial Resistance in Zimbabwe (NAP 2.0), where the Fleming Fund also announced an additional US$3.5 million in funding to address gaps in surveillance and improve the use of data for policymaking. Officiating at the launch of the Zimbabwe One Health AMR National Action Plan 2.0 (2024-2028) and the Fleming Fund II Grant, Dr. Douglas…
Read More